← back to search

Jin Li

Fudan University · CN
Area of research
Obstetrics and Gynecology · Oncology
Research interest
Research focused on Colorectal cancer and Trachelectomy, with related work in Odds ratio, Reperfusion injury, Regorafenib. Notable publications include 'Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer', 'Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer', and 'Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study'.
h-index
citations
836
works
9
NIH funding
primary concept
email

Recent publications

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
Journal of Clinical Oncology 2025cited by 14position: middledoi
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study
Therapeutic Advances in Medical Oncology 2025cited by 0position: middledoi
Nanoparticle–Patch System for Localized, Effective, and Sustained miRNA Administration into Infarcted Myocardium to Alleviate Myocardial Ischemia–Reperfusion Injury
ACS Nano 2024cited by 20position: middledoi
Enrichment mechanism of organic matter and silicon in lower Cambrian shale of the Yangtze Platform
Palaeogeography Palaeoclimatology Palaeoecology 2024cited by 14position: middledoi
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
Journal of Ovarian Research 2023cited by 48position: middledoi
Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study
American Journal of Obstetrics and Gynecology 2021cited by 61position: middledoi
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 <scp>CONCUR</scp> trial
Journal of Gastroenterology and Hepatology 2020cited by 16position: lastdoi
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
JAMA 2018cited by 396position: firstdoi
miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population
Tumor Biology 2015cited by 46position: middledoi
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
BMC Cancer 2014cited by 235position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jun Liang · Army Medical University1 papers (2020–2020)Zheng Feng · Shanghai Medical College of Fudan University1 papers (2023–2023)Rui‐Hua Xu · Henan Medical University1 papers (2020–2020)Hao Wen · University of Electronic Science and Technology of China1 papers (2023–2023)Yajun Yang · Fudan University1 papers (2015–2015)Xiaoyu Chen · Shanghai Medical College of Fudan University1 papers (2014–2014)Mengyun Wang · Ningbo University1 papers (2015–2015)Jen‐Kou Lin · National Yang Ming Chiao Tung University1 papers (2020–2020)Xiaofan Mei · Ministry of Education of the People's Republic of China1 papers (2024–2024)Yuhang Cai · Anhui Medical University1 papers (2023–2023)Yabiao Zheng · Soochow University1 papers (2015–2015)Na An · Shenyang Pharmaceutical University1 papers (2023–2023) · 1 papers (2020–2020)Jun Cao · Fudan University1 papers (2014–2014) · 1 papers (2024–2024)Fangyuan Shen · Soochow University1 papers (2015–2015)Shida Zhu · Harbin Medical University1 papers (2023–2023)Yueyin Pan · University of Science and Technology of China1 papers (2014–2014)Zhihui Xiu · Shandong University1 papers (2023–2023)Yihua Bei · Shanghai University1 papers (2024–2024)